The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
John389, two excerpts from broker note wrap-up: “Our 400p target price is based on the assumption that over the next 12 months the Medical Textiles division and the Heart Valve division will both make significant progress towards the potential £50m valuation of each that we have highlighted above.” “Obviously, both divisions are at a relatively early stage of development so there are risks as to, firstly, whether commercialisation will be achieved and, secondly, that this will occur in the timeframe we have anticipated.”
Can anyone confirm if the £4 share price target is a 12 month target ?
cheers Garuda
Bonker99.com/charts
********************/charts
Cockney where's best place to check the chart - can you post a link please?
Check the chart!!! She’s a whopper!!
Hmmm and then completely miss the re-rate. I’m holding and buying on dips - GLA
This looks more like a trading stock, sell on the spikes then wait for it to drift down.
Need to regain an upward momentum ...low selling volume bringing sp down here ...making my buy at the back end of last week look silly :-s
On the contrary, john389, all normal shareholders got a 3 for 10 open offer and the opportunity to apply for many more at 30p. In the end, 38% of all additional shares were made available. I expect Clive Titcomb’s additional shares were ALL from the recent issue. I do not know if he was included in the placing element of the fund raise though.
Someone thinks this is going somewhere....
Now could well be pretty reasonable timing .
Best of All
Couldnt be bothered to wait, but had to buy in 2 chunks
Yeah, i will be adding another 3.5k today if it hits 75p.
Well lets hope so, will be another great opportunity to add
I wouldnt be so quick to start predicting where the sp will end up. Its definitely on a upward trajectory, you will just have to be patient as it gradually moves up.
70s it is then :-/
Definitely got spiked last week then
Not lower, MMs still tree shaking for stock. £1 + very soon imho
This will be off again shortly, still very much undervalued in regards to the MCAP.
I hope no lower than that!
Doubt it imho
Do we reckon this will stable off now in the 70/80s until some news?
Thanks for reply.So he didn’t take part in the latest finance issue.Makes sense now
John389, Easy conclusion to come to on the bare stats but in reality the comparison is between * 6% of the pre-finance raise issued shares of around 5.6m * 4% of the post-finance raise issued shares of around 14.7m The answer is that Clive Titcomb’s interest has increased by around 260k shares to 590k, in round sum terms.